China’s First: Meio Cardinav Medical’s Innovative Cardiac Electrophysiology Interventional Surgery Control System “TITIAN” Approved for Market Launch
November 14, 2025 On October 31st, the Cardiac Electrophysiology Interventional Surgery Control System, branded as “TITIAN” developed by Meio Cardinav Medical, received market approval from...
The 1st Domestically Developed Invasive BCI Device Got Approved in China
“Mingtong (明瞳）,” a functional neurosurgical electrophysiological recording and stimulation device, has been officially approved for market release by China’s National Medical Products Administration (NMPA). Developed...
Just Medical Devices Announces Market Launch of the Biotype Knee Prosthesis System in China
Just Medical Devices (Tianjin) Co., Ltd., has announced the official market approval and launch of its groundbreaking Biotype Knee Prosthesis System. This product received official...
Zhongke Yian Medical Technology Launches High-nitrogen Nickel-free Stainless Steel Coronary Stent System
Zhongke Yian Medical Technology (Beijing) Co., Ltd. announced today the official market approval and launch of its innovative Sirolimus Drug-Eluting Coronary Stent System. Approved on...
The World’s First Pre-loaded, Dry-packaged TAVR System Approved by NMPA
On April 9, 2025, KingstronBio received approval from China’s National Medical Products Administration (NMPA) for its ProStyle A® Transcatheter Aortic Valve Replacement (TAVR) System. This...
A Landmark Achievement: Robo Medical’s Endoscopic Robot Approved for the Chinese Market
In a groundbreaking development for medical technology, the National Medical Products Administration (NMPA) of China has granted market approval to Robo Medical for its Control...
ECMO System from Hengrui Medical Has Gained NMPA Approval
Recently, Suzhou-based Hengrui Medical has announced its self-developed ECMO (Extracorporeal Membrane Oxygenation) system has been granted approval by the National Medical Products Administration (NMPA) in...
LoongCrystal®PR Type Intraocular Lens Receives the First Approval through NMPA’s Innovative Device Approval Channel in 2025
LoongCrystal®PR Type intraocular lens (IOL), developed by Eyebright Medical, has been approved for marketing by the National Medical Products Administration (NMPA) on January 6, 2025....